Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
Clinical trial NCT05243212 · RECRUITING
Trial details
- NCT number
- NCT05243212
- Sponsor
- Sheba Medical Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-19
- Primary completion
- 2024-09-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.